Search COSM
Cosmos Health Inc.
Nasdaq · CIK 1474167
Last close0.38
Daily change-0.01 (-1.55%)
10 Years gain-93.45%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
COSM · STANDARD
SIC 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Fiscal year end 1231
Fundamental
31.1Momentum
49.1Acceleration
29.5Confidence
71.0Annual Revenue13
Quarterly Revenue35
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth14.7 / 25
Quality4.7 / 25
Capital Efficiency0.0 / 20
Balance Sheet10.1 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Heavy share dilution · HIGHDiluted share count increased 130.141%.
ROIC declining · MEDIUMROIC declined by 13.4 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM27.55%OK
Revenue CAGR 3Y9.04%OK
Gross Margin9.68%OK
Operating Margin-13.92%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-28.64%OK
Incremental Operating Margin 3Y-53.04%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y130.14%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $65.27M | $7.90M | -$16.70M | -$8.45M | -$8.50M | 12.1% | -25.59% | -13.03% | -53.06% | 30.29M |
| 2025 FY Dec 31, 2024 | $54.43M | $4.31M | -$15.54M | -$7.72M | -$8.14M | 7.92% | -28.56% | -14.95% | -37.73% | 19.15M |
| 2024 FY Dec 31, 2023 | $53.38M | $4.35M | -$21.83M | -$15.64M | -$16.95M | 8.15% | -40.9% | -31.75% | -57.17% | n/a |
| 2023 FY Dec 31, 2022 | $50.35M | $5.96M | -$7.47M | -$14.87M | -$14.94M | 11.83% | -14.84% | -29.68% | -25.94% | n/a |
| 2022 FY Dec 31, 2021 | $56.24M | $8.33M | -$4.53M | -$7.10M | -$7.68M | 14.81% | -8.06% | -13.65% | -25.81% | 656,933 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $68.77M | sum latest 4 fiscal quarters Revenue | OK | 0001477932-26-005146, 0001477932-25-008322 |
| Revenue Growth TTM | 27.55% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001477932-26-005146, 0001477932-25-008322 |
| Revenue CAGR 3Y | 9.04% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001477932-26-002278 |
| Revenue CAGR 5Y | 3.33% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001477932-26-002278 |
| Gross Profit CAGR 3Y | 9.85% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001477932-26-002278 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001477932-26-005146, 0001477932-25-008322 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 9.68% | Gross Profit / Revenue | OK | 0001477932-26-005146, 0001477932-25-008322 |
| Operating Margin | -13.92% | Operating Income / Revenue | OK | 0001477932-26-005146, 0001477932-25-008322 |
| ROIC | -28.64% | NOPAT / Average Invested Capital | OK | 0001477932-26-005146, 0001477932-25-008322 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001477932-26-005146 |
| Current Ratio | 1.05x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.58x | (Cash + Short-term Investments) / Total Debt | OK | 0001477932-26-005146 |
| Revenue per Diluted Share | $1.15 | Revenue / Diluted Shares | OK | 0001477932-26-005146, 0001477932-25-008322 |